SEC Form 4 · accession 0000899243-18-021568
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel Agresta
Officer — Chief Medical Officer
Period of report
Aug 6, 2018
Accepted (ET)
Aug 7, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.80 | Aug 6, 2018 | A | 300,000 | A | — | Aug 6, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The option vests as to 12/48th of the shares on August 6, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.